Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-11-14 1:22 pm Purchase | 13G | BIO-TECHNE CORP COM TECH | PRICE T ROWE ASSOCIATES INC | 9,424,313 5.900% | 9,424,313 (New Position) | View |
2024-11-08 5:31 pm Unchanged | 13G | BIO-TECHNE CORP COM TECH | BlackRock Inc. BLK | 13,843,281 8.700% | 0 (Unchanged) | View |
2024-10-21 4:11 pm Sale | 13G | BIO-TECHNE CORP COM TECH | BlackRock Inc. BLK | 13,843,281 8.700% | -4,290,631 (-23.66%) | View |
2024-02-13 5:00 pm Purchase | 13G | BIO-TECHNE CORP COM TECH | VANGUARD GROUP INC | 18,228,210 11.530% | 28,778 (+0.16%) | View |
2024-01-24 09:46 am Purchase | 13G | BIO-TECHNE CORP COM TECH | BlackRock Inc. BLK | 18,133,912 11.500% | 2,245,272 (+14.13%) | View |
2023-02-09 11:12 am Purchase | 13G | BIO-TECHNE CORP COM TECH | VANGUARD GROUP INC | 18,199,432 11.590% | 13,772,794 (+311.13%) | View |
2023-01-26 08:52 am Unchanged | 13G | BIO-TECHNE CORP COM TECH | BlackRock Inc. BLK | 15,888,640 10.100% | 0 (Unchanged) | View |
2023-01-20 09:43 am Purchase | 13G | BIO-TECHNE CORP COM TECH | BlackRock Inc. BLK | 15,888,640 10.100% | 11,560,341 (+267.09%) | View |
2022-02-09 3:33 pm Purchase | 13G | BIO-TECHNE CORP COM TECH | VANGUARD GROUP INC | 4,426,638 11.270% | 111,095 (+2.57%) | View |
2022-01-27 11:00 am Unchanged | 13G | BIO-TECHNE CORP COM TECH | BlackRock Inc. BLK | 4,328,299 11.000% | 0 (Unchanged) | View |
2022-01-25 3:03 pm Sale | 13G | BIO-TECHNE CORP COM TECH | BlackRock Inc. BLK | 4,328,299 11.000% | -19,729 (-0.45%) | View |
2021-09-10 09:42 am Purchase | 13G | BIO-TECHNE CORP COM TECH | VANGUARD GROUP INC | 4,315,543 11.040% | 724,191 (+20.16%) | View |
2021-02-10 10:39 am Purchase | 13G | BIO-TECHNE CORP COM TECH | VANGUARD GROUP INC | 3,591,352 9.300% | 22,550 (+0.63%) | View |
2021-01-26 6:52 pm Purchase | 13G | BIO-TECHNE CORP COM TECH | BlackRock Inc. BLK | 4,348,028 11.300% | 507,931 (+13.23%) | View |
2020-02-12 07:57 am Purchase | 13G | BIO-TECHNE CORP COM TECH | VANGUARD GROUP INC | 3,568,802 9.360% | 125,053 (+3.63%) | View |
2020-02-10 2:19 pm Purchase | 13G | BIO-TECHNE CORP COM TECH | BlackRock Inc. BLK | 3,840,097 10.000% | 28,936 (+0.76%) | View |
2020-02-04 11:53 am Sale | 13G | BIO-TECHNE CORP COM TECH | BlackRock Inc. BLK | 3,811,161 9.990% | -44,787 (-1.16%) | View |